Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.
Lund, B Ryberg, M Petersen, P M Anderson, Heather Thatcher, Nick Dombernowsky, P
Lund, B
Ryberg, M
Petersen, P M
Anderson, Heather
Thatcher, Nick
Dombernowsky, P
Citations
Altmetric:
Abstract
Affiliation
Description
Date
1994-11
Publisher
Collections
Keywords
Lung Cancer
Cancer Staging
Cancer Staging
Type
Article
Citation
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer. 1994, 5 (9):852-3 Ann Oncol